Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647321 · ClinicalTrials.gov registry record · NA
Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis
A NA study of Secondary Progressive Multiple Sclerosis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01647321: Completed NA study of Secondary Progressive Multiple Sclerosis, sponsored by Johns Hopkins University.
NCT01647321 is a NA study of Secondary Progressive Multiple Sclerosis that has completed, run by Johns Hopkins University. The registered enrollment target is 16 participants, below the 495-participant average among 8 other Secondary Progressive Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01647321, a NA study of Secondary Progressive Multiple Sclerosis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS) for which there are no existing therapies that alter the disease course. This research will utilize cutting edge functional electrical stimulation (FES) cycling technology with the goal of improving walking in individuals with SPMS. The investigators hypothesize that FES cycling will improve walking in subjects with SPMS.
Primary Outcome
Here we will assess whether a subjects walking speed is improved following active cycling with functional electrical stimulation. Our prediction is that individuals will improve in their walking function following seated active cycling with functional electrical stimulation.
Conditions Studied
Interventions
- BEHAVIORAL Active cycling
- BEHAVIORAL Passive cycling
Study Locations (1)
Maryland
- Johns Hopkins / Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-10 |
| Phase | NA |
What the finished NCT01647321 record still lists
NCT01647321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 495-participant average among 8 other Secondary Progressive Multiple Sclerosis trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Secondary Progressive Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Active cycling is the first listed.
NCT01647321 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01647321 about?
NCT01647321 is a clinical study titled "Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis". Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS) for which there are no existing therapies that alter the disease course. This research will utilize cutting edge functional electrical stimulation (FES) cycling technology with the goal of improving walking in in...
What is the current status of trial NCT01647321?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-07. Estimated completion is 2019-10.
What conditions does trial NCT01647321 study?
This clinical trial studies the following conditions: Secondary Progressive Multiple Sclerosis.
What interventions are being tested in trial NCT01647321?
The interventions under investigation include: Active cycling (BEHAVIORAL), Passive cycling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01647321?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01647321 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Secondary Progressive Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01647321's enrollment target sits among peer trials
16 8th of 8 higher than 1 of 8 other Secondary Progressive Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Secondary Progressive Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
RECRUITING · Phase 2
-
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
RECRUITING · Phase 3
-
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
RECRUITING · Phase 3
-
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia